TORONTO, April 22, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier ...
The trial is real, and it is a meaningful step. It is also, by design, small, tightly controlled, and years away from ...
In recent years, there has been growing interest among adults with ADHD in the practice of microdosing classic psychedelics ...
President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
As psychedelics gain traction as potential treatments for mental health disorders, an international study led by researchers at McGill University, Imperial College London, and the University of Exeter ...
State lawmakers unanimously approved a measure to cultivate research into psychedelics and support clinical trials for the ...
The recent federal action directing the FDA to accelerate the review of psychedelic therapies marks a major shift in the development of next-generation mental health treatments. With regulatory ...
The bill was voted out of a committee this month as lawmakers and policy groups expressed concern about the use of opioid ...
Psychedelic clinical trials require a differentiated approach compared to traditional pharmaceutical studies. CenExel's operational framework is designed to help sponsors navigate these complexities ...
Commenters on the US Food and Drug Administration’s (FDA) first guidance on clinical investigations and drug development programs for psychedelic drugs raised concerns about decoupling drug ...
As Joe Rogan told it, President Donald Trump jumped at the chance to facilitate regulatory approval of ibogaine and other ...
As the field of mental health continues to evolve, psychedelic drugs are increasingly undergoing rigorous scientific research for their therapeutic potential. Molecules like psilocybin, MDMA, and DMT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results